US equities
|
NVDA
$241.57
▲+1.12%
SPCX
$173.16
▲+1.21%
MU
$1,063.14
▼-0.08%
AMD
$655.45
▲+3.75%
MRVL
$284.77
▲+4.98%
SNDK
$1,669.66
▼-2.02%
AVGO
$378.27
▲+4.35%
TSLA
$380.67
▲+0.51%
NVDA
$241.57
▲+1.12%
SPCX
$173.16
▲+1.21%
MU
$1,063.14
▼-0.08%
AMD
$655.45
▲+3.75%
MRVL
$284.77
▲+4.98%
SNDK
$1,669.66
▼-2.02%
AVGO
$378.27
▲+4.35%
TSLA
$380.67
▲+0.51%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Altamira Therapeutics Ltd.
Altamira Therapeutic’s RNA Delivery Platform Shown to be an Effective Treatment for Abdominal Aortic Aneurysm as Published in Peer-Reviewed Journal
July 12, 2022
From
Altamira Therapeutics Ltd.
Via
AccessWire
Topics
Death
Tickers
CYTO
Altamira Therapeutics Announces Top-Line Data from AM-125 Phase 2 Study in Acute Vertigo
June 13, 2022
From
Altamira Therapeutics Ltd.
Via
AccessWire
Tickers
CYTO